BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20141433)

  • 1. Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.
    Jayasekara H; Karahalios A; Juneja S; Thursfield V; Farrugia H; English DR; Giles GG
    Leuk Lymphoma; 2010 Mar; 51(3):456-68. PubMed ID: 20141433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
    van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
    Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.
    Storm HH; Klint A; Tryggvadóttir L; Gislum M; Engholm G; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):694-712. PubMed ID: 20491526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
    Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
    Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.
    Marcos-Gragera R; Allemani C; Tereanu C; De Angelis R; Capocaccia R; Maynadie M; Luminari S; Ferretti S; Johannesen TB; Sankila R; Karjalainen-Lindsberg ML; Simonetti A; Martos MC; Raphaël M; Giraldo P; Sant M;
    Haematologica; 2011 May; 96(5):720-8. PubMed ID: 21330324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.
    Dandoit M; Mounier M; Guy J; Petrella T; Girard S; Casasnovas RO; Martin L; Bonnetain F; Maynadié M
    Leuk Lymphoma; 2015 Apr; 56(4):1050-7. PubMed ID: 25166007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.
    Monnereau A; Troussard X; Belot A; Guizard AV; Woronoff AS; Bara S; Lapôtre-Ledoux B; Iwaz J; Tretarre B; Maynadié M;
    Int J Cancer; 2013 May; 132(10):2378-87. PubMed ID: 23034773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years.
    Linet MS; Brown LM; Mbulaiteye SM; Check D; Ostroumova E; Landgren A; Devesa SS
    Int J Cancer; 2016 Apr; 138(8):1862-74. PubMed ID: 26562742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of haematological neoplasms in Castilla y León, Spain].
    Rodríguez-García JA; Vázquez L; Ramos F; Cuevas B; Martín A; Smucler A; Guerola DN; Cantalapiedra A; Alonso JM; Fernández S; Díez E; Rodríguez MJ; Calmuntia MJ; Aguilar C; Sierra M; Gracia JA; Cebeira MJ; Cantalejo R;
    Med Clin (Barc); 2015 Jun; 144(11):491-500. PubMed ID: 25015251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Population-based incidence of lymphoid neoplasms by histological subtypes in Girona (Spain), 1994-2001].
    Marcos-Gragera R; Vilardell L; Izquierdo A; Masuet C; Gardella S; Bernado L; Sanjosé Sd; Moreno V
    Med Clin (Barc); 2006 Jan; 126(1):5-12. PubMed ID: 16409944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
    Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
    Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.
    Yoon SO; Suh C; Lee DH; Chi HS; Park CJ; Jang SS; Shin HR; Park BH; Huh J
    Am J Hematol; 2010 Oct; 85(10):760-4. PubMed ID: 20806229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-2002.
    Feltbower RG; McNally RJ; Kinsey SE; Lewis IJ; Picton SV; Proctor SJ; Richards M; Shenton G; Skinner R; Stark DP; Vormoor J; Windebank KP; McKinney PA
    Eur J Cancer; 2009 Feb; 45(3):420-7. PubMed ID: 19004628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.
    Smith A; Crouch S; Lax S; Li J; Painter D; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2015 Apr; 112(9):1575-84. PubMed ID: 25867256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex ratios and the risks of haematological malignancies.
    Cartwright RA; Gurney KA; Moorman AV
    Br J Haematol; 2002 Sep; 118(4):1071-7. PubMed ID: 12199787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and sex distributions of hematological malignancies in the U.K.
    McNally RJ; Rowland D; Roman E; Cartwright RA
    Hematol Oncol; 1997 Nov; 15(4):173-89. PubMed ID: 9722889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood cancers in Chennai, India, 1990-2001: incidence and survival.
    Swaminathan R; Rama R; Shanta V
    Int J Cancer; 2008 Jun; 122(11):2607-11. PubMed ID: 18324630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.